EUCTR2011-003474-86-FI进行中（未招募）不适用
Albumin in Acute Stroke (ALIAS) Trial-Part 2: A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection in Acute Ischemic Stroke - ALIAS
Myron D. Ginsberg0 个研究点目标入组 1,100 人开始时间: 2011年11月2日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Acute ischemic stroke
- •- Age 18 years through 83 years (have not had their 84th birthday).
- •- NIHSS score of 6 or greater as assessed immediately prior to intravenous thrombolysis treatment if the patient is eligible for intravenous thrombolysis or immediately prior to randomization for patients not eligible for intravenous thrombolysis.
- •- Initiation of ALB/placebo within 5 hours of stroke onset, and within 90 minutes of the start of thrombolysis with intravenous (IV) tPA if that therapy is used. Signed and dated informed consent has been obtained.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Episode/exacerbation of congestive heart failure (CHF) from any cause in the last 6 months.
- •- Known valvular heart disease with CHF in the last 6 months.
- •- Known (or in the Investigator’s clinical judgment) existence of severe aortic stenosis or mitral stenosis.
- •- Cardiac surgery involving thoracotomy in the last 6 months.
- •- Acute myocardial infarction in the last 6 months.
- •- Signs or symptoms of acute myocardial infarction, including EKG findings, on admission.
- •- Elevated serum troponin level on admission (> 0.1 mcg/L)
- •- Suspicion of aortic dissection on admission.
- •- Acute arrhythmia with hemodynamic instability on admission
- •- Findings on physical examination of any of the following: (1) jugular venous distention; (2) 3rd heart sound; (3) resting tachycardia attributable to congestive heart failure; (4) lower extremity pitting edema attributable to congestive heart failure; abnormal hepatojugular reflux; (5) bilateral rales; and/or (6) if a chest x-ray is performed, definite evidence of pulmonary edema, bilateral pleural effusion, or pulmonary vascular redistribution
- •- Current acute or chronic lung disease requiring supplemental chronic or intermittent oxygen therapy.
- •- Historical modified Rankin Scale (mRS) >2. Patients who live in a nursing home or who are not fully independent for activities of daily living, immediately prior to the stroke are not eligible for the trial.
- •- In-patient stroke. Patients with stroke occurring as a complication of hospitalization for another condition, or as a complication of a procedure.
- •- Profound dehydration.
- •- Fever, defined as core body temperature > 38.0oC
- •- Serum creatinine > 2.0 mg/dL or 180 ?mol/L
- •- Severe chronic anemia (hemoglobin < 7.5 g/dL or 75g/L).
- •- Evidence of intracranial hemorrhage (intracerebral hematoma, intraventricular hemorrhage, subarachnoid hemorrhage (SAH), epidural hemorrhage, acute or chronic subdural hematoma (SDH)) on the baseline CT or MRI scan.
- •- History of or known allergy to albumin.
- •- History of or known allergy to natural rubber latex.
- •- Pregnancy, breastfeeding or positive pregnancy test.
- •- Concurrent participation in any other therapeutic clinical trial.
- •- Evidence of any other major life-threatening or serious medical condition that would prevent completion of the study protocol, impair the assessment of outcome, or in which ALB therapy would be contraindicated or might cause harm to the subject.
研究者
相似试验
已完成
不适用
Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-strokeCognitive ImpairmentStrokeDouble AlbuminNCT04135872Dongguan People's Hospital435
已完成
3 期
Albumin in heart surgery? Effect of Starch in valve heart surgeryIRCT20190512043568N1Ragaei heart center80
已完成
2 期
Effect of Albumin on size of hematoma in Hemorrhagic StrokeHemorrhagic Stroke.Intracerebral Haemorrhage, UnspecifiedIRCT201201018574N1Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences60
招募中
不适用
Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid HemorrhagesAneurysmal Subarachnoid HemorrhageNCT06548477Hamad Medical Corporation84
进行中（未招募）
1 期
Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment forAcute Ischemic StrokeNCT06172387Tianjin Huanhu Hospital46